Matthew Stanton
Stock Analyst at Jefferies
(0.57)
# 4,109
Out of 5,090 analysts
7
Total ratings
50%
Success rate
-24.83%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Upgrades: Buy | $30 → $38 | $35.05 | +8.42% | 2 | Oct 30, 2025 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $164.98 | -18.17% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $9.54 | -16.14% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.43 | +127.27% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $25.46 | -13.59% | 1 | Apr 4, 2024 |
Azenta
Oct 30, 2025
Upgrades: Buy
Price Target: $30 → $38
Current: $35.05
Upside: +8.42%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $164.98
Upside: -18.17%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $9.54
Upside: -16.14%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.43
Upside: +127.27%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $25.46
Upside: -13.59%